AlloSource, of Centennial, Colorado, a non-profit provider of skin, bone and soft tissue allografts, has hired medical device veteran Dale Binke as the firm’s Vice President of Sales and Marketing. Binke has held senior leadership roles with Medtronic, Inc., Orthofix Interntional NV, Trinity Orthopedics and Spinal Elements, Inc.
Dale Binke New VP at AlloSource

“I am excited to use my experience for such a passionate, mission-driven company that is truly guided by an internal compass, ” said Binke. “AlloSource’s progressive innovation has the potential to help medical professionals heal many patients.”
Kevin Cmunt, AlloSource executive vice president, said in the April 23 press release, “Dale’s experience in the medical device industry makes him essential to the AlloSource team as it continues to add new distribution resources. With the sophistication of our new cellular tissue allografts, his senior leadership will help us position ourselves in the marketplace to ensure we honor the gift of donation by allowing it to help as many recipients as possible, ”
AlloSource offers more than 200 types of bone, skin, soft-tissue and custom-machined allografts for use in medical procedures and, according to company officials, is the world’s largest processor of cellular bone growth substitutes.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.